Carrie Cox
Voorzitter bij ORGANON & CO.
Vermogen: 11 M $ op 30-04-2024
Profiel
Mevrouw Carrie S. Cox is voorzitter bij Organon & Co., voorzitter bij Advantagene, Inc., voorzitter bij Selecta Biosciences, Inc., onafhankelijk bestuurder bij Cardinal Health, Inc., onafhankelijk bestuurder bij Texas Instruments Incorporated en lid van de raad van bestuur van het University of Pennsylvania Museum of Archaeology & Anthropolog. Zij zetelt in de Raad van Bestuur van Cardinal Health, Inc. en Texas Instruments Incorporated. Mevrouw Cox was voorheen werkzaam als Voorzitter bij Array BioPharma, Inc., als Voorzitter bij electroCore, Inc., als Onafhankelijk Bestuurder bij Celgene Corp., als President-Global Pharmaceuticals & Executive VP bij Schering-Plough Corp., als Senior Vice President-Global Business Management bij Pharmacia & Upjohn, Inc, President Global Prescription Business & EVP bij Pharmacia Corp., lid van de Harvard T.H. Chan School of Public Health, directeur bij Novartis Corp., voorzitter bij Prism Pharmaceuticals, Inc. en Vice President Women's Healthcare bij Wyeth-Ayerst Research. Zij was ook lid van de raad van bestuur van Humacyte, Inc. en Renetx Bio, Inc. Zij behaalde haar doctorale graad aan het Massachusetts College of Pharmacy & Health Science.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 28-02-2024 | 35 801 ( 0.00% ) | 6 M $ | 30-04-2024 | |
CARDINAL HEALTH, INC.
0.02% | 18-09-2023 | 41 631 ( 0.02% ) | 4 M $ | 30-04-2024 |
0.04% | 18-04-2024 | 7 096 ( 0.04% ) | 148 306 $ | 30-04-2024 |
ORGANON & CO.
-.--% | 08-04-2024 | 0 ( -.--% ) | - $ | 30-04-2024 |
Actieve functies van Carrie Cox
| Bedrijven | Functie | Begin |
|---|---|---|
| TEXAS INSTRUMENTS INCORPORATED | Directeur/Bestuurslid | 16-09-2004 |
| ORGANON & CO. | Voorzitter | 02-06-2021 |
| University of Pennsylvania Museum of Archaeology & Anthropolog | Corporate Officer/Principal | - |
Eerdere bekende functies van Carrie Cox
| Bedrijven | Functie | Einde |
|---|---|---|
| CARDINAL HEALTH, INC. | Directeur/Bestuurslid | 15-11-2023 |
| HUMACYTE, INC. | Algemeen Directeur | 01-06-2018 |
| CANDEL THERAPEUTICS, INC. | Voorzitter | 15-07-2021 |
| ELECTROCORE, INC. | Voorzitter | 31-03-2020 |
| CELGENE | Directeur/Bestuurslid | 01-11-2019 |
Opleiding van Carrie Cox
| Massachusetts College of Pharmacy & Health Science | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 6 |
|---|---|
| TEXAS INSTRUMENTS INCORPORATED | Electronic Technology |
| CARDINAL HEALTH, INC. | Distribution Services |
| ELECTROCORE, INC. | Health Technology |
| ORGANON & CO. | Health Technology |
| CANDEL THERAPEUTICS, INC. | Health Technology |
| HUMACYTE, INC. | Health Technology |
| Bedrijven in privébezit | 12 |
|---|---|
| Wyeth-Ayerst Research | |
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Humacyte Global, Inc.
 Humacyte Global, Inc. Medical SpecialtiesHealth Technology Humacyte Global, Inc. engages in the manufacture of human acellular matrix products for vascular and non-vascular applications. It offers its products to the cardiovascular, cosmetic, soft tissue reconstruction, neurosurgical, and orthopedic markets. The company was founded by Laura E. Niklason, Juliana L. Blum and Shannon L. M. Dahl in 2004 and is headquartered in Durham, NC. | Health Technology |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Health Technology |
Renetx Bio, Inc.
 Renetx Bio, Inc. BiotechnologyHealth Technology Renetx Bio, Inc. operates as a biotechnology company that develops disease modifying therapeutics. It offers Nogo Receptor and Cellular Prion Protein technology. The company was founded by Sylvia McBrinn and Stephen Strittmatter in 2009 and is headquartered in New Haven, CT. | Health Technology |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Health Technology |
| Pharmacia & Upjohn, Inc. | Health Technology |
| University of Pennsylvania Museum of Archaeology & Anthropolog | |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO. | Health Technology |
Prism Pharmaceuticals, Inc.
 Prism Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prism Pharmaceuticals, Inc. manufactures cardiovascular injectables and pharmaceutical products. The firm engages in developing and commercializing branded cardiovascular injectable products which include NEXTERONE. The company was founded by Gilbert R. Gonzales and Cameron Durrant in 2003 and is headquartered in King of Prussia, PA. | Health Technology |
Selecta Biosciences, Inc.
 Selecta Biosciences, Inc. BiotechnologyHealth Technology Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Its portfolio includes pipeline, autoimmune, gene therapy, and biologic therapy. The company was founded by Omid C. Farokhzad, Robert S. Langer Jr., and Ulrich von Andrian on December 10, 2007 and is headquartered in Watertown, MA. | Health Technology |